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Using Multiple Data Sets to Build a Surveillance
System for Hemoglobinopathies: Early Lessons from Georgia
Georgia RuSH Collaborative*

For more information, contact the Georgia Health Policy Center
at 404.413.0314 or visit us online at www.gsu.edu/ghpc.

BACKGROUND

Though the total number of individuals with hemoglobinopathies in
Georgia is uncertain, it is known that Georgia ranks among the top states
in sickle cell disease prevalence. Estimates range from as low as 4,981 to
as high as 8,427. Along with six other states, Georgia participated in the
two-year Registry and Surveillance System for Hemoglobinopathies
(RuSH) pilot project. Objectives: To determine the annual incidence and
five-year prevalence (2004-2008) of hemoglobinopathies in Georgia and
to describe the demographics of the populations living with these
disorders.

METHODS
Potential cases are identified from five sources: (1) the state newborn
screening program (NBS); (2) the Georgia hospital discharge file, which
includes most in-patient and emergency room visits in the state; (3) the
Grady, CHOA and GHSU health systems, including all outpatient visits; (4)
the State Medicaid and CHIP programs; and (5) the State Health Benefit
Plan (SHBP). Laboratory screening and confirmatory results, coupled with
clinical expertise, are used to confirm cases from NBS, Grady and GHSU
data. ICD-9 and CPT codes are used to identify probable and possible
cases from additional administrative datasets. Individual datasets are
examined to produce preliminary geographic estimates of prevalence
and to judge the potential overlap of cases prior to merging all datasets
into one surveillance system.

Figure 1: Georgia RuSH project case-finding data sets
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RESULTS
From 2004 through 2008, 1,009 newborns screened positive for a
hemoglobin disorder in Georgia. During that same time period, CHOA
treated approximately 2,580 pediatric patients with a hemoglobin disorder,
and Grady and GHSU treated approximately 1,600 and 1,450 patients,
respectively. Medicaid and CHIP programs paid claims for approximately
14,667 enrollees with a hemoglobinopathy-associated medical encounter,
while the SHBP covered such services for 1,737 enrollees. Lastly, close to
9,778 individuals were treated in a Georgia emergency room or hospital for a
hemoglobinopathy. (Figure 1) We estimate that up to 47 percent of the
9,778 individuals identified through state hospital discharge data may also
be present in one of the three hospital systems’ data. (Figure 2)

Close to 90 percent of the newborns identified through NBS are estimated to
be followed by one of the three hospital systems.
Using newborn screening data from 2004 through 2008 (Figure 4), we
identified the counties with the highest number of incident cases. Most cases
are found in the five metro Atlanta counties (Fulton, DeKalb, Cobb, Gwinnett
and Clayton) as well as the smaller metropolitan areas in South and
Southeastern Georgia.

Figure 4: Georgia newborns screening positive for sickle cell
disease, January 2004 through December 2008

Figure 2: Clinic Patient/Hospital Discharge Count Overlap,
2004-2008

As well, 55 percent of the Medicaid/CHIP patients and 32 percent of the
SHBP patients likely overlap with the hospital discharge file. However, 88
percent of Medicaid enrollees and 70 percent of SHBP enrollees ever coded
with a hemoglobinopathy had a hospitalization or ER visit from 2004 to
2008. (Figure 3)

Figure 3: Overlap between Health Insurance Claims data
and Georgia Hospital Discharge Data

CONCLUSION AND IMPLICATIONS
Early outcomes from the Georgia RuSH project have allowed us to identify
areas of the state to focus hemoglobinopathy outreach efforts. Further
progress will allow us to answer programmatic, policy and outreach questions
specific to Georgia, and aid the development of educational materials for
providers, policy-makers and legislators. Lessons learned can be shared with
other states interested in developing hemoglobinopathy surveillance systems.
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